research – NCARD

NCARD Secures Funding for Innovative Mesothelioma Imaging Study

1 year ago

The National Centre for Asbestos Related Diseases (NCARD) has been awarded $200,000 from the Medical Research Future Fund (MRFF) to support a new imaging trial for mesothelioma, an asbestos-related cancer.…

Spotlight on: Faith Hartley

News

1 year ago

Spotlight on Faith Hartley Feature Image

The National Centre for Asbestos-Related Diseases (NCARD) is proud to spotlight Faith Hartley, whose journey from honours student to PhD researcher demonstrates a strong commitment to improving cancer treatment. Faith…

NCARD expands expertise to transform childhood cancer treatment

News

1 year ago

NCARD expands expertise to transform childhood cancer treatment

The National Centre for Asbestos Related Diseases (NCARD) is bringing its internationally recognised expertise in cancer immunotherapy to improve outcomes for children with cancer. In collaboration with Perth Children’s Hospital…

Why study with NCARD? Listen to the latest podcast on our postgraduate opportunities

News, Podcast

1 year ago

Located in Western Australia, home to one of the world’s highest rates of asbestos-related cancers, the National Centre for Asbestos-Related Diseases (NCARD) leads the way in mesothelioma research. At NCARD,…

NCARD study links immune cell types to survival in lung cancer and mesothelioma

News

2 years ago

Congratulations to Dr Linda Ye, a PhD student at the National Centre for Asbestos Related Diseases (NCARD), along with her supervisors, Associate Professor Alec Redwood, Prof Jenette Creaney and Prof…

NCARD 2024 Annual Scientific Meeting – Public Lecture available online

Event, News, Video

2 years ago

The 2024 NCARD Annual Scientific Meeting was held on September 18th and 19th at the Harry Perkins Building in QEII Medical Centre. The event included a Public Lecture on the…

Breakthrough research giving new hope for treatment of dust diseases

News

2 years ago

Through icare, the Dust Diseases Board has funded Dr Alistair Cook’s research over three years endeavouring to create better outcomes for patients who are diagnosed with mesothelioma. Dr Cook was…

Genetically engineered MexTAg mice advance understanding of asbestos-related cancer

News

2 years ago

At the National Centre of Asbestos Related Diseases (NCARD), we have produced many cutting-edge preclinical tools and models to support our research. These efforts are largely focused on the rare…

Copper-Binding Drugs: A New Approach to Mesothelioma Therapy

News

2 years ago

Copper-Binding Drugs A New Approach to Mesothelioma Therapy

The National Centre for Asbestos Related Diseases (NCARD) proudly announces that one of its projects has been awarded funding through the 2024 Cancer Council WA Research Project Grant scheme. This…

Trial increases survival rates for mesothelioma patients

News, Publications

2 years ago

A breakthrough clinical trial has found that combining a new drug with chemotherapy treatment improved survival rates of malignant mesothelioma patients. The study, published in JAMA Oncology, was led by…

World leader in respiratory medicine recognised

News

2 years ago

An expert in respiratory health at The University of Western Australia has been awarded the Eric Susman Prize for work in the field of Pleural Medicine. Professor Gary Lee, a…

NCARD’s Annual Scientific Symposium Sheds Light on Mesothelioma Breakthroughs

Event, News

3 years ago

The National Centre for Asbestos Related Diseases (NCARD) recently hosted its annual Scientific Symposium, a hallmark event that united top experts in mesothelioma research. The day was filled with discussions…

NCARD well-represented at iMig 2023

News

3 years ago

This year, NCARD researchers and students travelled to Lille, France to attend the 16th International Conference of the International Mesothelioma Interest Group (iMig) held on 26 – 28 June. iMig,…

The iMig conference returns for 2023!

Event, News

3 years ago

The 16th International Conference of the international Mesothelioma interest group (iMig) will soon be held in Lille, France on June 26-28 2023. This year, the iMig conference will be hosted…

NCARD Secures Funding for Innovative Mesothelioma Imaging Study

Spotlight on: Faith Hartley

NCARD expands expertise to transform childhood cancer treatment

Why study with NCARD? Listen to the latest podcast on our postgraduate opportunities

NCARD study links immune cell types to survival in lung cancer and mesothelioma

NCARD 2024 Annual Scientific Meeting – Public Lecture available online

Breakthrough research giving new hope for treatment of dust diseases

Genetically engineered MexTAg mice advance understanding of asbestos-related cancer

Copper-Binding Drugs: A New Approach to Mesothelioma Therapy

Trial increases survival rates for mesothelioma patients

World leader in respiratory medicine recognised

NCARD’s Annual Scientific Symposium Sheds Light on Mesothelioma Breakthroughs

NCARD well-represented at iMig 2023

The iMig conference returns for 2023!

National Centre for Asbestos Related Diseases

Latest News

Recent Posts

Scientific Publications

Subscribe

Contacts